Parkinson's
Disease
(PD)
is
a
neurodegenerative
disorder
that
affects
the
motor
system
of
human
body.
Currently,
available
treatments
are
limited
and
often
have
undesirable
side
effects.
In
this
context,
aim
study
was
to
develop
novel
combinational
formulation
Apomorphine
Quetiapine
evaluate
its
efficacy
in
rat
model
PD.
The
prepared
using
solvent
evaporation
technique
characterized
for
physicochemical
properties.
in-vitro
drug
release
evaluated
Franz
diffusion
cell
method,
pharmacokinetics
combination
studied
rats.
behavioural
biochemical
parameters
were
rats
Rotarod,
pole
test,
assays.
results
showed
developed
had
satisfactory
properties
exhibited
sustained
release.
pharmacokinetic
studies
longer
residence
time
than
individual
drugs.
effective
improving
function
reducing
oxidative
stress.
conclusion,
promising
stress
Further
required
safety
humans.
Frontiers in Aging Neuroscience,
Год журнала:
2024,
Номер
15
Опубликована: Янв. 17, 2024
The
unique
anatomical
and
physiological
connections
between
the
nasal
cavity
brain
provide
a
pathway
for
bypassing
blood–brain
barrier
to
allow
direct
brain-targeted
drug
delivery
through
administration.
There
are
several
advantages
of
administration
compared
with
other
routes;
example,
first-pass
effect
that
leads
metabolism
orally
administered
drugs
can
be
bypassed,
poor
compliance
associated
injections
minimized.
Nasal
also
help
maximize
delivery,
allowing
high
pharmacological
activity
at
lower
dosages,
thereby
minimizing
likelihood
adverse
effects
providing
highly
promising
treatment
central
nervous
system
diseases.
aim
this
review
article
was
briefly
describe
structures
brain,
pathways
which
enter
nose,
factors
affecting
methods
improve
systems
application
related
biomaterials,
common
experimental
used
in
intranasal
research,
current
limitations
such
approaches,
solid
foundation
further
in-depth
research
on
(see
Graphical
Abstract
).
Journal of Drug Delivery Science and Technology,
Год журнала:
2023,
Номер
87, С. 104820 - 104820
Опубликована: Авг. 4, 2023
The
essential
oils
extracted
from
Pistacia
lentiscus
resins
possess
promising
antiproliferative
effects
against
ovarian
and
breast
cancer
cells
because
of
their
high
content
bioactive
compounds.
However,
PO
has
many
drawbacks
that
hinder
its
application
in
therapy,
such
as
increased
volatility,
hydrophobicity,
limited
bioavailability.
In
this
study,
niosomal
formulation
loaded
with
oil
(PO)
was
formulated
improved
stability
cytotoxicity
two
cell
lines.
regard,
the
Chios
mastic
utilizing
a
green
approach,
hydrodistillation.
Its
chemical
composition
analyzed
using
gas-chromatography–mass
spectrometry.
loaded-niosomes
(PO/Ns)
were
prepared
thin-film
hydration
method.
nanovesicles
spherical
had
an
average
size
230.3
±
3.7
nm,
polydispersity
index
0.13
0.03,
ζ
potential
(ZP)
−20.36
4.89
mV.
PO/Ns
entrapment
efficiency
(EE)
80.59
3.37%
displayed
sustained
release
manner
(83.74
3.34%)
over
72
h.
Moreover,
developed
exhibited
outstanding
terms
size,
PDI,
ZP,
EE%
when
stored
for
21
days.
SRB
assay
showed
IC50
values
(Skov-3)
(MCF-7)
lines
57.04
to
69.1
μg/mL
4.88
7.38
μg/mL,
respectively,
encapsulated
niosomes
(PO/Ns).
Loading
by
10-folds
Skov-3
MCF-7
cells.
On
other
hand,
safety
both
evident
computed
>200
normal
epithelial
line
(MCF10A).
enhanced
apoptotic
(combined
early
late
apoptosis)
9-fold
4-fold
cells,
compared
unloaded
treatment.
Cell
cycle
analysis
revealed
mainly
targets
sub-G1
phase,
where
it
traps
providing
further
evidence
induction
apoptosis
SKOV-3
Real-time
PCR
(RT-qPCR)
performed
quantify
gene
expression
pro-apoptotic
markers
Bak
Bax,
well
antiapoptotic
marker
Bcl-2
upon
exposure
treatments.
Both
demonstrated
remarkable
ability
upregulate
downregulate
Bcl-2.
As
expected,
upregulation
genes
mitochondrial
death
significantly
higher
than
pure
treatment
among
investigated
(Skov-3
MCF-7).
Essential
into
significant
cytotoxic
Pharmaceutics,
Год журнала:
2023,
Номер
16(1), С. 58 - 58
Опубликована: Дек. 29, 2023
Alzheimer's
disease,
a
progressive
neurodegenerative
condition,
is
characterized
by
gradual
decline
in
cognitive
functions.
Current
treatment
approaches
primarily
involve
the
administration
of
medications
through
oral,
parenteral,
and
transdermal
routes,
aiming
to
improve
function
alleviate
symptoms.
However,
these
treatments
face
limitations,
such
as
low
bioavailability
inadequate
permeation.
Alternative
invasive
methods,
while
explored,
often
entail
discomfort
require
specialized
assistance.
Therefore,
development
non-invasive
efficient
delivery
system
crucial.
Intranasal
has
emerged
potential
solution,
although
it
constrained
unique
conditions
nasal
cavity.
An
innovative
approach
involves
use
nano-carriers
based
on
nanotechnology
for
intranasal
delivery.
This
strategy
overcome
current
limitations
providing
enhanced
bioavailability,
improved
permeation,
effective
traversal
blood-brain
barrier,
extended
retention
within
body,
precise
targeting
brain.
The
comprehensive
review
focuses
advancements
designing
various
types
nano-carriers,
including
polymeric
nanoparticles,
metal
lipid
liposomes,
nanoemulsions,
Quantum
dots,
dendrimers.
These
are
specifically
tailored
therapeutic
agents
aimed
at
combatting
disease.
In
summary,
utilization
systems
show
significant
surmounting
constraints
disease
strategies.
Nevertheless,
essential
acknowledge
regulatory
well
toxicity
concerns
associated
with
this
route;
meticulous
consideration
required
when
engineering
carrier.
underscores
revolutionize
management
highlights
importance
addressing
considerations
safe
implementations.
Embracing
could
lead
substantial
field
treatment.
Topical
and
transdermal
drug
delivery
are
advantageous
administration
routes,
especially
when
treating
diseases
conditions
with
a
skin
etiology.
Nevertheless,
conventional
dosage
forms
often
lead
to
low
therapeutic
efficacy,
safety
issues,
patient
noncompliance.
To
tackle
these
novel
topical
platforms
involving
nanotechnology
have
been
developed.
This
review
focuses
on
the
latest
advances
regarding
development
of
nanoemulgels
for
application,
encapsulating
wide
variety
molecules,
including
already
marketed
drugs
(miconazole,
ketoconazole,
fusidic
acid,
imiquimod,
meloxicam),
repurposed
(atorvastatin,
omeprazole,
leflunomide),
natural-derived
compounds
(eucalyptol,
naringenin,
thymoquinone,
curcumin,
chrysin,
brucine,
capsaicin),
other
synthetic
molecules
(ebselen,
tocotrienols,
retinyl
palmitate),
wound
healing,
appendage
infections,
inflammatory
diseases,
cancer,
neuropathy,
or
anti-aging
purposes.
Developed
formulations
revealed
adequate
droplet
size,
PDI,
viscosity,
spreadability,
pH,
stability,
release,
permeation
and/or
retention
capacity,
having
more
characteristics
than
current
formulations.
In
vitro
in
vivo
studies
established
efficacy
developed
formulations,
confirming
their
potential,
making
them
promising
replacement
therapies,
as
possible
adjuvant
treatments,
which
might
someday
effectively
reach
market
help
fight
highly
incident
systemic
conditions.
Frontiers in Medicine,
Год журнала:
2024,
Номер
11
Опубликована: Сен. 19, 2024
Neuropsychiatric
disorders
are
multifaceted
syndromes
with
confounding
neurological
explanations.
It
includes
anxiety,
depression,
autism
spectrum
disorder,
attention
deficit
hyperactivity
schizophrenia,
Tourette’s
syndrome,
delirium,
dementia,
vascular
cognitive
impairment,
and
apathy
etc.
Globally,
these
occupy
15%
of
all
diseases.
As
per
the
WHO,
India
has
one
largest
populations
people
mental
illnesses
worldwide.
The
blood-brain
barrier
(BBB)
makes
it
extremely
difficult
to
distribute
medicine
target
cells
in
brain
tissues.
However,
is
possible
through
novel
advancements
nanotechnology,
molecular
biology,
neurosciences.
One
such
cutting-edge
delivery
method,
nose-to-brain
(N2B)
drug
using
nanoformulation
(NF),
overcomes
traditional
formulation
limitations.
Later
offers
more
controlled
release,
better
bioavailability,
improved
patient
acceptance,
reduced
biological
interference,
circumvention
BBB.
When
medicines
delivered
via
intranasal
(IN)
route,
they
enter
nasal
cavity
go
connections
between
olfactory
trigeminal
nerves
mucosa
N2B.
Delivering
phytochemical,
bioactive
synthetic
NF
being
investigated
N2B
strategy.
mucociliary
clearance,
enzyme
degradation,
translocations
by
efflux
mechanisms
significant
issues
associated
delivery.
This
review
article
discusses
types
neuropsychiatric
their
treatment
plant-derived
as
well
drug-loaded
NFs
administered
IN-delivery
system.
In
conclusion,
this
provided
a
comprehensive
critical
overview
IN
applicability
for
psychiatric
disorders.
Pharmaceutics,
Год журнала:
2023,
Номер
15(3), С. 998 - 998
Опубликована: Март 20, 2023
Depression
and
anxiety
are
high
incidence
debilitating
psychiatric
disorders,
usually
treated
by
antidepressant
or
anxiolytic
drug
administration,
respectively.
Nevertheless,
treatment
is
given
through
the
oral
route,
but
low
permeability
of
blood–brain
barrier
reduces
amount
that
will
be
able
to
reach
it,
thus
consequently
reducing
therapeutic
efficacy.
Which
why
it
imperative
find
new
solutions
make
these
treatments
more
effective,
safer,
faster.
To
overcome
this
obstacle,
three
main
strategies
have
been
used
improve
brain
targeting:
intranasal
route
which
allows
directly
transported
neuronal
pathways,
bypassing
avoiding
hepatic
gastrointestinal
metabolism;
use
nanosystems
for
encapsulation,
including
polymeric
lipidic
nanoparticles,
nanometric
emulsions,
nanogels;
molecule
functionalization
ligand
attachment,
such
as
peptides
polymers.
Pharmacokinetic
pharmacodynamic
in
vivo
studies’
results
shown
administration
can
efficient
targeting
than
other
routes,
nanoformulations
quite
advantageous
increasing
brain–drug
bioavailability.
These
could
key
future
improved
therapies
depressive
disorders.
Russian Journal of General Chemistry,
Год журнала:
2023,
Номер
93(7), С. 1867 - 1899
Опубликована: Июль 1, 2023
Abstract
The
review
focuses
on
the
lipid
based
nanocarriers,
with
special
attention
paid
to
natural
bioactive
payloads.
First,
micelles
and
microemulsions
are
considered
as
very
attractive
colloidal
nanocontainers
that
allow
for
marked
improving
solubility
of
hydrophobic
bioactives.
Further,
liposomal
vehicles
reviewed,
both
advantages
limitations
discussed.
Literature
assay
covers
up-to-date
information
about
last
three
five
years,
although
brief
background
is
given
pioneer
works
addressing
liposomes
their
evolution
from
bench
bedside.
Final
part
devoted
modern
modifications
vesicular
nanocarriers
which
can
be
adapted
specific
administration
way
due
improved
targeting
properties,
permeability,
mucoadhesiveness
possibility
cross
biological
barriers.
Therein,
such
kinds
transfersomes,
niosomes,
ethosomes,
chitosomes
evaluated;
separate
sections
focus
formulations,
i.e.,
phytosomes
invasomes.
Journal of Aerosol Medicine and Pulmonary Drug Delivery,
Год журнала:
2024,
Номер
37(5), С. 284 - 298
Опубликована: Апрель 26, 2024
Traditional
vaccines
have
played
an
important
role
in
the
prevention
and
treatment
of
infectious
diseases,
but
they
still
problems
such
as
low
immunogenicity,
poor
stability,
difficulty
inducing
lasting
immune
responses.
In
recent
years,
nucleic
acid
vaccine
has
emerged
a
relatively
cheap
safe
new
vaccine.
Compared
with
traditional
vaccines,
some
unique
advantages,
easy
production
storage,
scalability,
consistency
between
batches.
However,
direct
administration
naked
is
not
ideal,
safer
more
effective
delivery
systems
are
needed.
With
rapid
development
nanocarrier
technology,
combination
gene
therapy
nanodelivery
broadened
therapeutic
application
molecular
biology
medical
biological
nanomaterials.
Nanoparticles
can
be
used
potential
drug-delivery
vehicles
for
hereditary
diseases.
addition,
due
to
advantages
lung
immunity,
onset
action,
good
efficacy,
reduced
adverse
reactions,
pulmonary
become
hot
spot
field
research.
lipid
nanocarriers
safe,
efficient,
ideal
materials
their
physical
chemical
properties,
which
effectively
reduce
toxic
side
effects
drugs
achieve
effect
slow
release
controlled
release,
there
been
large
number
studies
using
efficiently
deliver
target
components
into
body.
Based
on
tuberculosis
(TB)
by
carrier,
this
article
systematically
reviews
mechanism
liposomes
so
lay
solid
foundation
faster
anti-TB
future.